<html>
<head>PUBMED IDs for ELAC2</head>
<body bgcolor='#C5F0F2'><h1>ELAC2</h1><a href='https://pubmed.ncbi.nlm.nih.gov/10986046/'>Association of HPC2/ELAC2 genotypes and prostate cancer.</a> September 14  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11175785/'>A candidate prostate cancer susceptibility gene at chromosome 17p.</a> February 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11175773/'>Prostate cancer: simplicity to complexity.</a> February 15  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254449/'>HPC2 variants and screen-detected prostate cancer.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11254448/'>Evaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancer.</a> March 20  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11295633/'>Prostate cancer chemoprevention: Strategies for designing efficient clinical trials.</a> April 11  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11431329/'>Polymorphisms in the prostate cancer susceptibility gene HPC2/ELAC2 in multiplex families and healthy controls.</a> June 30  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11507049/'>ELAC2/HPC2 involvement in hereditary and sporadic prostate cancer.</a>  8  Laboratory of Cancer Genetics, Institute of Medical Technology, University of Tampere and Tampere University Hospital, FIN-33101 Tampere, Finland. loanro@uta.fi,<br><a href='https://pubmed.ncbi.nlm.nih.gov/11522646/'>Role of HPC2/ELAC2 in hereditary prostate cancer.</a> August 28  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11673416/'>Heterogeneity of genetic alterations in prostate cancer: evidence of the complex nature of the disease.</a> October 24  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/12021166/'>Perspective: prostate cancer susceptibility genes.</a> May 22  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12085959/'>Prostate cancer susceptibility genes: many studies, many results, no answers.</a> June 28  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12373607/'>HPC2/ELAC2 polymorphisms and prostate cancer risk: analysis by age of onset of disease.</a> October 10  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12384782/'>ELAC2 and prostate cancer risk in Afro-Caribbeans of Tobago.</a> October 18  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12446782/'>hSnm1 colocalizes and physically associates with 53BP1 before and after DNA damage.</a> November 26  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12515253/'>Meta-analysis of associations of the Ser217Leu and Ala541Thr variants in ELAC2 (HPC2) and prostate cancer.</a> January 8  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12522685/'>Association of common missense changes in ELAC2 ( HPC2) with prostate cancer in a Japanese case-control series.</a> January 11  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12552947/'>Association of HPC2/ELAC2 polymorphism with prostate cancer risk in a Japanese population.</a> January 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12569551/'>The product of the candidate prostate cancer susceptibility gene ELAC2 interacts with the gamma-tubulin complex.</a> February 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12711671/'>A candidate prostate cancer susceptibility gene encodes tRNA 3' processing endoribonuclease.</a> April 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12783937/'>ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancer.</a> June 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12790786/'>Prostate cancer susceptibility genes: lessons learned and challenges posed.</a> June 7  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12949798/'>Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.</a> September 2  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14504198/'>Association of HPC2/ELAC2 polymorphisms with risk of prostate cancer in a population-based study.</a> September 25  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601030/'>Genome linkage screen for prostate cancer susceptibility loci: results from the Mayo Clinic Familial Prostate Cancer Study.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601029/'>Genome-wide scan for prostate cancer susceptibility genes using families from the University of Michigan prostate cancer genetics project finds evidence for linkage on chromosome 17 near BRCA1.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14601028/'>Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.</a> November 6  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14625808/'>HPC2/ELAC2 gene variants associated with incident prostate cancer.</a> November 20  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14648103/'>Genetic polymorphisms and prostate cancer risk.</a> December 3  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14695991/'>Mutational analysis of susceptibility genes RNASEL/HPC1, ELAC2/HPC2, and MSR1 in sporadic prostate cancer.</a> December 30  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/14749351/'>The complex genetic epidemiology of prostate cancer.</a> January 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15114533/'>Graphical modeling of the joint distribution of alleles at associated loci.</a> April 29  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15358515/'>Structure of primate and rodent orthologs of the prostate cancer susceptibility gene ELAC2.</a> September 11  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15368467/'>HPC2/ELAC2 polymorphism associated with Japanese sporadic prostate cancer.</a> September 16  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15714208/'>Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene.</a> February 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15824169/'>Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 with prostate cancer severity in European American and African American men.</a> April 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15863270/'>The missense mutations in the candidate prostate cancer gene ELAC2 do not alter enzymatic properties of its product.</a> May 3  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/15892892/'>Characterization of TRZ1, a yeast homolog of the human candidate prostate cancer susceptibility gene ELAC2 encoding tRNase Z.</a> May 17  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16267836/'>Prevalent mutations in prostate cancer.</a> November 4  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16636667/'>ELAC2, a putative prostate cancer susceptibility gene product, potentiates TGF-beta/Smad-induced growth arrest of prostate cells.</a> April 26  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16648113/'>Molecular biology in prostate cancer.</a> May 2  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16869093/'>Involvement of the RNAse L gene in prostate cancer.</a> July 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16869076/'>[Preparation of transgenic rats expressing human CD4, CCR5 and MHC class II transactivator and HIV-1 infection of peripheral mononuclear cells].</a> July 28  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/18375959/'>Sequence variants of elaC homolog 2 (Escherichia coli) (ELAC2) gene and susceptibility to prostate cancer in the Health Professionals Follow-Up Study.</a> April 1  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18767027/'>Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases.</a> September 4  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19555350/'>Functional conservation of tRNase ZL among Saccharomyces cerevisiae, Schizosaccharomyces pombe and humans.</a> September 17  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19933153/'>A novel class of small RNAs: tRNA-derived RNA fragments (tRFs).</a> December 16  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20086112/'>Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20086108/'>Genetic variation in prostaglandin E2 synthesis and signaling, prostaglandin dehydrogenase, and the risk of colorectal adenoma.</a> May 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20231859/'>ELAC2 polymorphisms and prostate cancer risk: a meta-analysis based on 18 case-control studies.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20819227/'>Identification and analysis of candidate fungal tRNA 3'-end processing endonucleases tRNase Zs, homologs of the putative prostate cancer susceptibility protein ELAC2.</a> December 24  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21559454/'>Localization of human RNase Z isoforms: dual nuclear/mitochondrial targeting of the ELAC2 gene product by alternative translation initiation.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21559452/'>Resistance of renal cell carcinoma to sorafenib is mediated by potentially reversible gene expression.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21559450/'>Preclinical models for neuroblastoma: establishing a baseline for treatment.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21559449/'>Generation of a predictive melphalan resistance index by drug screen of B-cell cancer cell lines.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21593607/'>Involvement of human ELAC2 gene product in 3' end processing of mitochondrial tRNAs.</a> April 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21627373/'>Associations of polymorphisms in HPC2/ELAC2 and SRD5A2 genes with benign prostate hyperplasia in Turkish men.</a> October 1  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21781332/'>A survey of green plant tRNA 3'-end processing enzyme tRNase Zs, homologs of the candidate prostate cancer susceptibility protein ELAC2.</a> December 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21857155/'>RNA processing in human mitochondria.</a> March 20  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23141781/'>Genetic analysis of the principal genes related to prostate cancer: a review.</a> August 5  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23141775/'>A novel p.Leu213X mutation in GJB2 gene in a Portuguese family.</a> July 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23157136/'>[Epidemiology and risk factors of the prostate cancer].</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23157044/'>Impact of Factor V Leiden, prothrombin and methylenetetrahydrofolate reductase gene mutations on infant birth weight in women with recurrent fetal loss and women with successful pregnancies.</a> December 12  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23849775/'>ELAC2 mutations cause a mitochondrial RNA processing defect associated with hypertrophic cardiomyopathy.</a> December 18  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23849771/'>Genetic factors and multiple sclerosis in the Moroccan population: a role for HLA class II.</a> August 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23849770/'>[Interleukin-1 and the interleukin-1 receptor antagonist gene polymorphisms study in patients with rheumatoid arthritis].</a> August 26  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/26241669/'>A Novel WRN Frameshift Mutation Identified by Multiplex Genetic Testing in a Family with Multiple Cases of Cancer.</a> May 11  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26251261/'>Prognostic role of genetic biomarkers in clinical progression of prostate cancer.</a> January 27  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26251247/'>Remote Ischemic Conditioning Alters Methylation and Expression of Cell Cycle Genes in Aneurysmal Subarachnoid Hemorrhage.</a> December 15  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27318894/'>Association between RNASEL, MSR1, and ELAC2 single nucleotide polymorphisms and gene expression in prostate cancer risk.</a> June 20  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28276031/'>Analysis of Mitochondrial RNA-Processing Defects in Patient-Derived Tissues by qRT-PCR and RNAseq.</a> March 10  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28596295/'>Genetic variance is associated with susceptibility for cigarette smoke-induced DAMP release in mice.</a> June 10  2017<br></body></html>
